glp-1 liver disease masld The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis GLP-1 RECEPTOR AGONISTS HAVE A – Frontiers | Future Perspectives on

Serious adverse events are uncommon but may include: Pancreatitis or gallbladder inflammation Allergic reactions Rare gastrointestinal disturbances Because of these potential risks, GLP-1 therapy should always be initiated and monitored by a doctor experienced in metabolic medicine

Living with a complex, invisible illness like Long COVID, ME/CFS, or dysautonomia is an incredibly isolating and exhausting experience

As we age, our brains capacity to process, recall, and adapt can diminish

If you are also worried that your intake has quietly dropped more than you realized, this piece on eating too little on Ozempic may help you spot the pattern earlier

This is smart practice, especially during summer months when ambient temperatures can cause the fridge to work harder and cycle more aggressively

These are the hallmarks of a healthy GH/IGF-1 axis, and these are the conditions under which a healthy HPTA can thrive